What is the current valuation of the GCC fertility services market?

The market valuation was $1182.23 Million in 2024. Read More

What is the projected market size for the GCC fertility services market by 2035?

The projected valuation for 2035 is $4216.82 Million. Read More

What is the expected CAGR for the GCC fertility services market during 2025 - 2035?

The expected CAGR during this period is 12.26%. Read More

Which treatment type holds the highest market value in the GCC fertility services market?

In Vitro Fertilization had a market value of $500.0 Million in 2024, indicating strong demand. Read More

How does the market value for male infertility compare to female infertility in 2024?

Female infertility was valued at $300.0 Million, while male infertility was valued at $200.0 Million. Read More

What segment is projected to grow the most in the GCC fertility services market?

The treatment services segment, valued at $827.57 Million in 2024, is likely to see substantial growth. Read More

Which end user category had the highest market valuation in 2024?

Fertility clinics and hospitals both had a market valuation of $354.67 Million in 2024. Read More

What is the market value for surrogacy services in the GCC fertility services market?

Surrogacy services were valued at $232.23 Million in 2024. Read More

Who are the key players in the GCC fertility services market?

Key players include IVF Australia, Fertility Centers of Illinois, and CCRM Fertility, among others. Read More

What is the market value for consultation services in the GCC fertility services market?

Consultation services were valued at $118.22 Million in 2024. Read More

GCC Fertility Services Market

ID: MRFR/HC/43239-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

GCC Fertility Services Market Research Report: Size, Share, Trend Analysis By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs) - Growth Outlook & Industry Forecast 2025 To 2035

GCC Fertility Services Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Treatment Type (USD Million)
  1. 4.1.1 In Vitro Fertilization
  2. 4.1.2 Intracytoplasmic Sperm Injection
  3. 4.1.3 Artificial Insemination
  4. 4.1.4 Donor Egg
  5. 4.1.5 Surrogacy
2. 4.2 Life Sciences, BY Patient Type (USD Million)
  1. 4.2.1 Female Infertility
  2. 4.2.2 Male Infertility
  3. 4.2.3 Couples with Unexplained Infertility
  4. 4.2.4 Same-Sex Couples
  5. 4.2.5 Single Parents
3. 4.3 Life Sciences, BY End User (USD Million)
  1. 4.3.1 Fertility Clinics
  2. 4.3.2 Hospitals
  3. 4.3.3 Home Care
4. 4.4 Life Sciences, BY Service Type (USD Million)
  1. 4.4.1 Consultation Services
  2. 4.4.2 Diagnostic Services
  3. 4.4.3 Treatment Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 IVF Australia (AU)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fertility Centers of Illinois (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 CCRM Fertility (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 New Hope Fertility Center (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Reproductive Health Specialists (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Fertility Associates (NZ)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Clinica de Fertilidad (ES)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 IVF Spain (ES)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bourn Hall Clinic (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY TREATMENT TYPE
3. 6.3 GCC MARKET ANALYSIS BY PATIENT TYPE
4. 6.4 GCC MARKET ANALYSIS BY END USER
5. 6.5 GCC MARKET ANALYSIS BY SERVICE TYPE
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TREATMENT TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY PATIENT TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY SERVICE TYPE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PATIENT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY SERVICE TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Life Sciences Market Segmentation

Life Sciences By Treatment Type (USD Million, 2025-2035)

In Vitro Fertilization
Intracytoplasmic Sperm Injection
Artificial Insemination
Donor Egg
Surrogacy

Life Sciences By Patient Type (USD Million, 2025-2035)

Female Infertility
Male Infertility
Couples with Unexplained Infertility
Same-Sex Couples
Single Parents

Life Sciences By End User (USD Million, 2025-2035)

Fertility Clinics
Hospitals
Home Care

Life Sciences By Service Type (USD Million, 2025-2035)

Consultation Services
Diagnostic Services
Treatment Services

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”